An unusual case report illuminates the therapeutic potential of psilocybin and neuroplasticity.
Read morePharmacists and Safe Consumption of Psychedelic Medicines Upon Their FDA Approval
Upon the FDA approval of psychedelic medicine for psychiatric indications—such as MDMA for post-traumatic stress disorder or psilocybin for depression—psychiatric pharmacists in particular and all pharmacists generally, will play a pivotal role in the psychedelic medicine market in the US.
Read moreEcstasy and Psilocybin Are Shaking Up Psychiatry
Researchers are looking at how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
Read moreLooking at Psychedelics and Legalization
Michael Pollan looks at the legalization of some psychedelics and asks how should we do drugs now?
Read moreCan a Bad Trip Be a Good Thing?
Psychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read morePsychedelics As Medicine
Psychedelics are promising treatments for mental illness. Dozens of new startups have sprung up to develop and deliver the drugs to patients in need.
Read moreResearch of Psychedelics
How Magic Mushrooms Evolved
Why does nature produce hallucinogenic compounds? One study set out to uncover the answer... keep reading to find out more.
Read more50 Years of Psychedelic Progress
Check out this Q&A with Beckley Psytech Director & Chair of Scientific Advisory Board, Lady Amanda Feilding.
Amanda Feilding has been called the ‘hidden hand’ behind the renaissance of psychedelic science. Her contribution to global drug policy reform and to opening the doors to scientific research has been pivotal and widely acknowledged.
Read morePsilocybin and Terminally Ill Patients
This new study suggests that psilocybin may reduce suicidal thoughts in terminally ill patients.
Read moreLegalization vs. Decriminalization
Here’s some helpful information for understanding legalization v. decriminalization with psychedelics.
Read more